Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design

ABSTRACTThe personalized neoantigen nanovaccine (PNVAC) platform for patients with gastric cancer we established previously exhibited promising anti-tumor immunoreaction. However, limited by the ability of traditional neoantigen prediction tools, a portion of epitopes failed to induce specific immun...

Full description

Bibliographic Details
Main Authors: Kai Xin, Xiao Wei, Jie Shao, Fangjun Chen, Qin Liu, Baorui Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2023.2300881